Main text
Disease control amongst refugee populations is a critical component of the global response with COVID-19 [1]. Another critical issue for refugees is the maintenance of life-saving care for non-communicable and chronic infectious diseases, including diabetes and HIV/AIDS. In Jordan, Syrian refugees with non-communicable diseases typically access clinical care and medications at no cost through clinics supported by humanitarian organizations. Since January, the International Rescue Committee in Jordan has been conducting a study on the impact of supplementing clinical care with out-of-clinic support through a Syrian community health volunteer network, on adherence to medications and prevention of severe outcomes among Syrians and uninsured Jordanians with poorly controlled diabetes and/or hypertension (ClinicalTrials.gov, NCT04229667). It is notable that these patients (elderly, with multi-morbidities, and tenuous access to care), are also a major risk group for poor outcomes from COVID-19 infection [2].
On March 21, 2020, the Government of Jordan implemented national curfews to impel social distancing, including the temporary closure of clinics for refugees [3]. As clinical care is resumed, it is important to think about how to use community health volunteers to mitigate the impact of COVID-19 in this population. First, using clinic lists of diabetics and hypertensives, CHVs could help patients connect with pharmacies to ensure access to a two-month supply of medication and insulin and provide monthly follow-up by telephone for monitoring and assessment for complications from pre-existing disease. This would serve dually as infection prevention for elderly patients, minimizing their potential exposure to infected persons at primary care clinics, and would mitigate the impact of interruptions to life-saving treatment [4]. Second, community health volunteers could provide refugees with a trusted connection to surveillance systems, risk communication, and the epidemic response, which is a major aim of community engagement [5].
Such “switching-on” of remote strategies to reach patients cut-off from care is common but less documented in the literature. This has included providing “run-away” bags of antiretrovirals and a hotline for HIV/AIDS patients, and using community health volunteers to refer malnourished children and provide counseling on infant and young child feeding during deteriorations in security in Yemen [6, 7]. As with acute conflict, for COVID-19, the decision to use CHVs or other health workers to reach households is critically-dependent on operating safely (e.g. not entering households and using protection), defining a necessarily-reductive role without excessive duties, providing a critical link with health services, and securing the trust of a willing workforce. Ministries of Health and humanitarian organizations are likely thinking of such strategies for reaching vulnerable populations. We should support them with technical guidance.
Acknowledgements
None.
Authors’ contributions
MF, FR, PP, RR jointly developed the concept for the letter and contributed to writing the letter. The authors read and approved the final manuscript.
Funding
This study referenced in this letter is funded by Elrha’s Research for Health in Humanitarian Crises programme, which aims to improve health outcomes by strengthening the evidence base for public health interventions in humanitarian crises (project no. 28368). The Research for Health in Humanitarian Crises programme is funded equally by the Wellcome Trust and the UK Department for International Development. Visit www.elrha.org/r2hc for more information. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had final responsibility for the decision to submit for publication.
Availability of data and materials
Not applicable.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Dahab M, van Zandvoort K, Flasche S, Warsame A, Spiegel PB, Waldman RJ, Checchi F. COVID-19 control in low-income settings and displaced populations: what can realistically be done? London: London School of Hygiene & Tropical Medicine; 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. [DOI] [PMC free article] [PubMed]
- 3.Younes A: Round-the-clock curfew in Jordan to battle coronavirus outbreak. Doha: AlJazeera; 2020. https://www.aljazeera.com/news/2020/03/jordan-announces-clock-curfew-coronavirus-outbreak-320184824472.html.
- 4.Boulle P, Kehlenbrink S, Smith J, Beran D, Jobanputra K. Challenges associated with providing diabetes care in humanitarian settings. Lancet Diabetes Endocrinol. 2019;7(8):648–56. [DOI] [PubMed]
- 5.Risk Communication and Community Engagement Working Group on COVID-19 Preparedness and Response, WHO, IFRC, OCHA . COVID-19: How to include marginalized and vulnerable people in risk communication and community engagement. 2020. [Google Scholar]
- 6.Ferreyra C, O'Brien D, Alonso B, Al-Zomour A, Ford N. Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen. Confl Health. 2018;12:30. doi: 10.1186/s13031-018-0161-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ahmadzai TK, Maburutse Z, Miller L, Ratnayake R. Protecting public health in Yemen. Lancet. 2016;388(10061):2739. doi: 10.1016/S0140-6736(16)32422-9. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Not applicable.